Skip to main content

Table 1 CD38 and LMP1 expression in NKTCL

From: CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma

 

Number of cases

Positivity score

3

2

1

0

CD38

10

4

3

1

2

LMP1

10

2

3

3

2